≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Injury of nerves at ankle and foot level

Endpoint Browser

ST19_INJURY_NERVES_ANKLE_FOOT_LEVEL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — S94
  • Cause of death: ICD-10 — S94

2 out of 7 registries used, show all original rules.

261

4. Check minimum number of events

None

261

5. Include endpoints

None

261

6. Filter based on genotype QC (FinnGen only)

261

Control definitions (FinnGen only)

Control exclude
ST19_INJURI_ANKLE_FOOT

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
S90
Name in latin
Laesio nervorum regionis tarsi/pedis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 261 146 115
Unadjusted period prevalence (%) 0.05 0.05 0.05
Median age at first event (years) 45.55 42.28 49.69

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
229
Matched controls
2289
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S94.3
ICD-10 Finland
Injury of cutaneous sensory nerve at ankle and foot level
+∞
96.9
86
*
S94.2
ICD-10 Finland
Injury of deep peroneal nerve at ankle and foot level
+∞
42.0
39
*
S94.8
ICD-10 Finland
Injury of other nerves at ankle and foot level
+∞
40.9
38
*
S94.9
ICD-10 Finland
Injury of unspecified nerve at ankle and foot level
+∞
32.0
30
*
S93.4
ICD-10 Finland
Sprain and strain of ankle
9.8
25.1
53
68
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.5
22.6
102
346
X58
ICD-10 Finland
Exposure to other specified factors
5.8
21.8
69
158
X59
ICD-10 Finland
Exposure to unspecified factor
4.9
21.2
81
229
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
206.1
18.8
19
*
S94.0
ICD-10 Finland
Injury of lateral plantar nerve
+∞
17.9
17
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
8.6
17.6
39
53
S94.7
ICD-10 Finland
Injury of multiple nerves at ankle and foot level
+∞
15.8
15
*
N03AX16
ATC
pregabalin; oral
3.6
15.7
86
325
N03AX12
ATC
gabapentin; oral
4.4
15.1
60
170
M79.6
ICD-10 Finland
Pain in limb
3.2
14.4
104
476
W19
ICD-10 Finland
Unspecified fall
5.6
14.3
43
90
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
13.8
105
495
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
5.6
11.9
35
71
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
7.7
11.7
27
39
M25.5
ICD-10 Finland
Pain in joint
2.9
11.6
88
401
S94.1
ICD-10 Finland
Injury of medial plantar nerve
+∞
11.5
11
*
N06AX21
ATC
duloxetine; oral
4.4
11.5
43
113
N02BE01
ATC
paracetamol; systemic, rectal
3.9
11.2
207
1621
S91.3
ICD-10 Finland
Open wound of other parts of foot
19.0
10.9
16
9
M19.0
ICD-10 Finland
Primary arthrosis of other joints
5.0
10.3
33
74
WX320
NOMESCO Finland
Spinalanesthesy
3.1
10.2
66
268
S18
ICPC
Laceration/cut
2.5
10.0
107
587
Z3226
NOMESCO Finland
Physiotherapist
3.1
9.6
57
219
L16
ICPC
Ankle symptom/complaint
4.4
9.6
35
90
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
18.5
9.5
14
8
S93.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of foot
104.1
9.5
10
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
9.4
121
724
R4110
NOMESCO Finland
Physiotherapy
2.7
9.3
74
340
TQW40
NOMESCO Finland
Remowal of suture of skin
5.5
9.3
27
54
NHF25
NOMESCO Finland
Operation for debridement of ankle joint, arthroscopic
19.6
9.0
13
7
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.9
9.0
38
112
N02AX02
ATC
tramadol; systemic, rectal
2.4
8.9
106
606
NH1AD
NOMESCO Finland
Ankle and foot CT
14.8
8.8
14
10
W22
ICD-10 Finland
Striking against or struck by other object(s)
5.1
8.8
27
58
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
7.4
8.8
20
29
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.2
8.4
32
86
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
8.4
101
575
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
15.2
8.3
13
9
S06.0
ICD-10 Finland
Concussion
3.9
8.2
34
99
ZXA00
NOMESCO Finland
Right side
2.6
7.8
66
311
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
15.7
7.8
12
8
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
46.6
7.8
9
*
ACC29
NOMESCO Finland
Reconstruction of peripheral nerve: other or unspecified
46.6
7.8
9
*
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
10.6
7.6
14
14
S92.3
ICD-10 Finland
Fracture of metatarsal bone
26.0
7.6
10
*
A02BC02
ATC
pantoprazole; systemic
2.2
7.5
149
1049
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
4.2
7.5
28
74
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.4
7.4
35
114
N06AA09
ATC
amitriptyline; systemic
3.9
7.3
30
86
N03AX09
ATC
lamotrigine; oral
5.1
7.2
22
47
S93.2
ICD-10 Finland
Rupture of ligaments at ankle and foot level
31.1
7.2
9
*
M89.0
ICD-10 Finland
Algoneurodystrophy
14.4
7.0
11
8
XA402
NOMESCO Finland
ENMG
7.1
6.9
16
24
S82.6
ICD-10 Finland
Fracture of lateral malleolus
4.4
6.9
24
59
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
9.8
6.9
13
14
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
11.4
6.9
12
11
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
5.2
6.9
20
41
T93.2
ICD-10 Finland
Sequelae of other fractures of lower limb
17.3
6.8
10
6
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
10.5
6.6
12
12
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
6.6
69
360
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
71.7
6.5
7
*
B01AB05
ATC
enoxaparin; parenteral
2.2
6.4
72
388
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
6.4
56
266
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
6.4
94
570
M54.5
ICD-10 Finland
Low back pain
2.2
6.4
83
475
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
6.3
71
379
T93.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of lower limb
18.6
6.3
9
5
NG4AA
NOMESCO Finland
Lower leg X-ray examination
5.8
6.1
16
29
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
6.1
32
113
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.0
6.1
18
38
SAA01
NOMESCO Finland
Simple examination of mouth
2.1
6.0
171
1335

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019069) Monocytes/100 leukocytes in Blood
149
958
2.29
9.76
6.9
6.1
%
8.0
8.5
0.95
138
906
(3006504) Eosinophils/100 leukocytes in Blood
148
953
2.28
9.61
6.5
5.9
%
3.0
2.7
0.87
135
896
(3018010) Neutrophils/100 leukocytes in Blood
150
985
2.23
9.11
6.4
5.7
%
56.1
57.0
0.38
139
932
(3002030) Lymphocytes/100 leukocytes in Blood
151
996
2.22
9.05
6.6
5.9
%
29.0
28.6
0.18
138
941
(3013115) Eosinophils [#/volume] in Blood
156
1062
2.17
8.39
7.1
6.0
e9/l
0.2
0.2
0.61
140
937
(3022096) Basophils/100 leukocytes in Blood
140
922
2.12
8.12
6.6
5.9
%
0.7
0.7
0.10
129
865
(3006315) Basophils [#/volume] in Blood
150
1028
2.08
7.66
6.5
5.8
e9/l
0.0
0.0
0.42
128
891
(3001604) Monocytes [#/volume] in Blood
149
1024
2.06
7.49
6.5
5.8
e9/l
0.6
0.6
1.66
130
886
(3019198) Lymphocytes [#/volume] in Blood
150
1066
1.96
6.51
6.5
5.8
e9/l
2.1
1.9
0.72
133
945
(3007853) Bacteria identified in Skin by Aerobe culture
47
228
2.29
5.68
2.5
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
160
1201
1.86
5.48
9.3
9.2
e9/l
4.3
4.1
0.48
138
1044
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
142
1037
1.81
5.23
6.8
6.2
umol/l
11.2
10.9
0.18
135
978
(42870588) Differential panel, method unspecified - Blood
100
658
1.84
5.18
6.9
5.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
95
2.80
4.98
1.8
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
52
278
2.09
4.92
2.2
1.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
80
507
1.83
4.59
4.4
3.5
%
90.4
94.0
0.64
80
497
(3023368) Bacteria identified in Blood by Culture
76
476
1.84
4.52
4.4
4.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
73
453
1.85
4.46
2.1
1.7
mg/l
0.9
1.1
0.58
52
346
(3024561) Albumin [Mass/volume] in Serum or Plasma
110
772
1.73
4.43
4.6
4.6
g/l
35.0
36.6
1.90
102
727
(3013707) Erythrocyte sedimentation rate by Westergren method
187
1524
1.80
4.37
4.9
3.6
mm/h
10.2
9.6
0.33
173
1415
(3037467) Urinalysis macro (dipstick) panel - Urine
176
1425
1.72
4.04
4.6
3.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
101
711
1.69
3.92
2.2
1.8
pmol/l
100.4
96.4
0.37
59
367
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
55
325
1.88
3.88
3.2
3.4
ng/l
1020.8
146.3
0.59
35
225
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
73
476
1.74
3.72
3.2
2.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
40
215
2.02
3.71
12.3
17.2
inr
1.0
1.3
—
8
31
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
128
973
1.62
3.60
4.3
3.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
100
716
1.64
3.57
5.9
6.5
inr
1.1
1.2
1.88
24
230
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
75
2.65
3.55
2.9
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
36
3.45
3.52
2.6
2.1
u/ml
0.3
0.3
—
7
21
(3042936) Bacteria identified in Isolate by Culture
47
273
1.88
3.48
2.3
2.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
76
512
1.68
3.41
7.9
6.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
32
3.54
3.37
1.7
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
29
144
2.14
3.31
1.7
2.1
e9/l
4.0
3.8
0.19
19
117
(3000494) Fungus identified in Specimen by Culture
41
232
1.91
3.28
1.5
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
20
85
2.47
3.24
2.0
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
97
705
1.60
3.19
3.8
3.2
e6/l
117.4
92.8
0.13
74
488
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
68
454
1.67
3.13
2.4
2.0
mg/l
3.2
3.0
0.27
55
388
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
185
1568
1.62
3.09
9.0
7.1
u/l
76.2
74.6
0.24
174
1472
(3044640) Blood type and Crossmatch panel - Blood
89
640
1.59
3.04
3.0
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
114
870
1.55
3.00
6.6
6.3
mmol/l
1.2
1.2
0.10
103
737
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
107
810
1.54
2.89
6.9
5.4
mmol/l
1.2
1.2
0.20
100
733
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
9
6.79
2.88
4.3
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
76
533
1.60
2.86
3.5
2.7
e6/l
0.2
0.3
0.26
60
400
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
18
4.55
2.81
3.5
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
144
1168
1.52
2.80
5.8
4.3
mmol/l
6.4
6.6
0.38
137
1069
(3019225) pH of Specimen
31
170
1.93
2.73
4.2
4.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
73
2.42
2.71
2.9
1.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
60
403
1.63
2.67
2.8
2.3
e6/l
7.1
5.5
0.18
54
358
(3017143) Hepatitis C virus Ab [Presence] in Serum
50
321
1.69
2.64
1.6
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
105
808
1.50
2.56
2.4
2.2
nmol/l
72.8
75.5
0.54
93
726
(3019550) Sodium [Moles/volume] in Serum or Plasma
233
2131
1.87
2.56
18.0
12.8
mmol/l
139.5
139.7
0.53
228
2072
(3023103) Potassium [Moles/volume] in Serum or Plasma
234
2143
1.89
2.56
17.6
12.9
mmol/l
4.0
4.0
0.20
229
2080
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
223
2016
1.73
2.53
14.8
10.8
ml/min/173m2
87.8
87.3
0.12
191
1630
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
95
719
1.51
2.50
3.1
3.0
u/l
33.7
30.6
0.35
90
683
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
77
557
1.54
2.50
2.4
2.1
u/l
1038.7
375.7
0.43
72
527
(3002582) Erythrocytes [#/volume] in Urine
81
593
1.53
2.49
3.3
2.8
e6/l
10.1
163.7
0.80
68
456
(3002032) Base excess in Venous blood by calculation
27
146
1.95
2.48
2.7
3.5
mmol/l
3.4
2.1
0.68
18
108
(3005719) IgG [Mass/volume] in Serum or Plasma
28
154
1.92
2.45
3.1
2.2
g/l
9.2
10.5
1.22
22
139
(3003694) ABO and Rh group [Type] in Blood
86
642
1.51
2.40
1.5
1.6
—
—
—
0
0
(3012544) pH of Venous blood
28
156
1.89
2.37
2.7
3.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
32
187
1.81
2.34
1.9
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
293
1.65
2.26
2.7
2.5
e6/l
2.1
2.8
0.21
22
154
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
94
723
1.47
2.25
3.5
3.2
ng/l
16.7
34.7
2.07
56
447
(3021960) Folate [Moles/volume] in Serum or Plasma
59
413
1.55
2.20
1.6
1.4
nmol/l
18.3
20.6
0.68
48
351
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
233
2151
1.78
2.20
18.3
11.8
mg/l
19.7
21.7
0.48
197
1655
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
299
0.47
2.18
1.3
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
72
529
1.50
2.15
3.6
2.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
116
936
1.43
2.13
9.1
9.0
e9/l
0.0
0.0
0.56
97
764
(40761511) CBC panel - Blood by Automated count
243
2277
1.97
2.10
14.8
10.9
—
—
—
0
0
(3026782) Osmolality of Urine
55
383
1.55
2.10
3.1
2.5
mosm/kgh2o
543.5
577.8
0.63
50
331
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
186
1.76
2.09
2.0
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
46
308
1.60
2.07
2.8
2.4
e6/l
1.2
0.7
0.24
23
169
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
20
3.57
2.07
1.4
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
20
3.57
2.07
1.4
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
20
3.57
2.07
1.4
2.0
—
—
—
0
0
(4024509)
6
16
3.81
1.94
2.3
1.1
—
—
—
0
0
(4062490)
7
22
3.24
1.89
1.3
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
258
0.48
1.87
1.8
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
40
2.56
1.86
2.5
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
12
4.23
1.83
1.0
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
38
251
1.60
1.81
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
102
825
1.39
1.78
2.2
2.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
10
41
2.50
1.77
1.2
2.1
g/l
0.3
0.8
—
5
35
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
118
1.85
1.76
2.3
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
87
686
1.40
1.76
3.7
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
179
1589
1.40
1.75
3.8
3.9
pmol/l
14.6
14.7
0.14
165
1453
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
82
2.01
1.73
1.9
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
50
356
1.50
1.72
1.3
1.3
iu/ml
11.7
25.0
1.79
16
120
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
13
3.90
1.72
1.0
1.1
iu/ml
186.8
128.5
—
5
13
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
25
2.85
1.66
1.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
25
2.85
1.66
1.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
49
2.30
1.66
1.0
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
180
1608
1.38
1.64
3.4
3.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
43
300
1.52
1.63
2.0
1.6
nmol/l
995.4
1198.0
0.84
30
236
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
242
2295
1.75
1.56
12.1
9.2
u/l
28.7
26.8
0.92
236
2230
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
23
139
1.72
1.54
2.3
2.1
ug/l
15.2
8.2
0.35
15
125
(3045414) Leukocytes [Presence] in Urine
16
86
1.92
1.54
2.3
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
24
147
1.70
1.54
1.3
1.2
—
24.0
—
0
9
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
15
3.38
1.53
1.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
51
2.21
1.53
3.3
2.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
40
281
1.50
1.47
1.4
1.4
titre
1560.0
506.7
—
7
63
(3044290) Cell count panel - Cerebral spinal fluid
9
40
2.29
1.41
3.2
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
35
242
1.52
1.39
1.2
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
70
552
1.37
1.39
3.4
2.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
23
2.65
1.37
1.3
2.0
—
—
—
0
0
(1002224) Polysomnography panel
17
98
1.79
1.34
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
41
297
1.45
1.31
2.2
2.3
ug/g
110.1
117.2
0.06
32
239
(44790048)
5
18
2.81
1.29
2.4
1.7
—
—
—
0
0
(44806118)
5
18
2.81
1.29
2.4
1.7
—
—
—
0
0
(44790047)
5
18
2.81
1.29
2.4
1.7
—
—
—
0
0
(44790049)
5
18
2.81
1.29
2.4
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
18
2.81
1.29
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
62
485
1.37
1.29
1.8
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
26
2.34
1.19
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
26
2.34
1.19
1.3
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
46
347
1.40
1.19
1.3
1.3
u/ml
1.1
8.3
2.65
15
144
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
45
339
1.40
1.17
2.2
1.7
%
1.6
1.4
0.97
40
303
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
20
2.53
1.15
5.0
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
23
153
1.55
1.10
5.7
4.2
%
0.5
0.1
—
8
43
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
41
1.98
1.09
1.3
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
32
2.22
1.09
1.9
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
32
2.22
1.09
1.9
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
59
471
1.33
1.07
1.7
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
77
638
1.29
1.07
3.5
2.5
u/l
72.3
54.5
0.53
72
597
(3015377) Calcium [Moles/volume] in Serum or Plasma
74
611
1.29
1.06
2.5
3.4
mmol/l
2.3
2.3
0.01
63
546
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
206
1932
1.31
1.01
5.0
4.5
mu/l
1.7
2.4
0.63
193
1784
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
35
2.03
1.00
2.1
3.5
e9/l
4.1
4.6
—
7
35
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
23
2.20
0.98
1.4
1.1
promille
0.6
1.3
—
5
18
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
5
23
2.20
0.98
1.4
2.1
mmol/l
6.5
7.2
—
5
16
(3015736) pH of Urine
94
807
1.26
0.98
3.0
3.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
36
1.97
0.98
2.1
3.7
%
56.0
57.1
—
7
36
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
125
1.56
0.97
1.1
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
30
218
1.42
0.97
8.6
6.8
mmol/l
105.3
104.1
0.79
30
213
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
51
1.79
0.95
1.8
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
217
2055
1.33
0.95
17.0
12.0
%
40.6
40.7
0.05
179
1631
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
41
316
1.35
0.95
2.1
2.8
mmol/l
2.5
2.4
0.71
36
280
(3013512) EKG study
63
518
1.29
0.93
4.0
3.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
94
1.63
0.92
3.3
3.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
28
2.17
0.92
1.3
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
24
169
1.46
0.91
6.0
4.0
%
1.1
0.8
—
9
52
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
57
464
1.29
0.91
3.1
2.9
ng/l
969.4
1154.2
0.26
47
385
(3035350) Ketones [Presence] in Urine by Test strip
116
1027
1.23
0.91
3.6
3.3
estimate
0.0
0.0
0.00
23
207
(46235355) HIV 1 and 2 tests - Meaningful Use set
69
576
1.27
0.90
2.1
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
187
1.43
0.89
3.0
3.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
20
137
1.50
0.87
3.9
7.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
32
241
1.37
0.86
5.3
3.9
%
29.9
31.8
0.41
20
163
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
206
1.40
0.86
1.4
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
45
1.80
0.85
1.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
65
543
1.26
0.85
4.0
3.6
ph
7.4
7.4
—
9
93
(3034770) Mitochondria Ab [Titer] in Serum
10
57
1.78
0.85
1.0
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
11
65
1.72
0.83
1.7
1.4
ug/g
256.8
309.5
—
6
36
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
73
1.67
0.83
1.6
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
81
1.64
0.83
4.0
3.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
14
90
1.59
0.80
3.4
9.2
mmol/l
24.5
24.2
0.14
14
83
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
74
1.65
0.79
1.6
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
54
1.69
0.75
1.9
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
60
504
1.25
0.75
5.0
4.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
75
861
0.82
0.73
2.5
2.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
76
1.61
0.73
1.6
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
250
2442
1.56
0.70
25.6
17.3
e12/l
4.5
4.6
1.52
243
2378
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
219
2099
1.27
0.70
4.1
4.0
mmol/l
4.8
4.7
0.66
203
1979
(3007164) IgA [Mass/volume] in Serum or Plasma
55
463
1.24
0.68
1.4
1.4
g/l
2.3
2.3
0.13
34
293
(3010813) Leukocytes [#/volume] in Blood
250
2444
1.54
0.67
25.7
17.3
e9/l
7.1
6.6
2.96
244
2379
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
198
1881
1.22
0.66
5.9
4.9
mmol/mol
38.6
39.1
0.32
186
1776
(3025159) Blasts/100 leukocytes in Blood
20
146
1.40
0.66
5.4
4.3
%
0.0
0.3
—
6
38
(3021601) Nitrite [Presence] in Urine by Test strip
113
1023
1.18
0.66
5.1
4.5
estimate
0.0
0.0
0.00
25
210
(3003396) Base excess in Arterial blood by calculation
25
190
1.35
0.65
9.2
7.6
mmol/l
2.8
1.0
0.90
19
147
(3011397) Hemoglobin [Presence] in Urine by Test strip
54
456
1.23
0.65
3.2
3.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
87
1.52
0.64
6.5
7.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
59
504
1.22
0.64
1.4
1.3
u/ml
0.8
1.2
0.58
19
151
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
71
1.57
0.63
1.3
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
114
1036
1.18
0.63
3.6
3.3
estimate
0.0
0.0
0.00
23
198
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
88
1.50
0.62
1.2
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
30
1.68
0.61
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
30
1.68
0.61
1.6
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
30
1.68
0.61
1.6
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
30
1.68
0.61
1.6
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
22
166
1.36
0.61
10.4
8.3
%
94.6
96.1
0.42
22
158
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
167
1569
1.18
0.60
3.8
2.9
u/l
58.4
43.7
0.91
160
1488
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
64
1.58
0.59
1.2
1.3
—
3.2
—
0
9
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
23
0.00
0.58
0.0
3.5
—
86.2
—
0
23
(3026493) Urate [Moles/volume] in Serum or Plasma
58
500
1.21
0.57
2.8
2.6
umol/l
13180.6
7212.3
0.19
47
437
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
36
1.68
0.57
1.0
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
249
2439
1.45
0.57
25.7
17.3
e9/l
259.5
250.8
1.31
243
2384
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
10
65
1.56
0.56
1.2
1.3
—
8.6
—
0
12
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
37
1.64
0.56
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
39
1.55
0.53
1.2
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
104
949
1.16
0.53
3.2
2.7
ug/l
97.3
100.9
0.11
98
885
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
9
134
0.66
0.53
7.7
3.7
mmol/l
1.2
1.2
—
9
116
(3029937) Albumin [Presence] in Urine by Test strip
48
557
0.83
0.52
4.2
3.5
estimate
0.0
0.0
0.00
25
206
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
40
1.51
0.52
1.8
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
101
1.41
0.50
1.3
1.4
miu/ml
249.0
316.4
—
8
48
(3002179) Metamyelocytes/100 leukocytes in Blood
20
154
1.32
0.50
5.1
4.0
%
0.6
0.4
—
5
33
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
46
1.54
0.48
2.1
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
111
1.37
0.48
1.3
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
216
2090
1.19
0.47
4.2
3.9
mmol/l
1.4
1.4
1.94
200
1959
(3025941) Bacteria identified in Stool by Culture
17
129
1.34
0.47
1.7
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
49
1.44
0.46
2.0
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
49
1.44
0.46
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
152
0.71
0.45
3.9
3.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
50
1.41
0.45
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
1.6
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
1.6
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
31
1.62
0.43
1.4
3.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.6
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
32
1.57
0.42
2.0
2.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
8
58
1.39
0.42
1.3
1.3
—
46.6
—
0
6
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
2.0
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
15
0.00
0.41
0.0
1.1
—
1.1
—
0
5
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
59
1.37
0.41
1.5
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
1.1
—
0
16
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
355
0.82
0.41
1.3
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
17
0.00
0.41
0.0
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
34
1.48
0.40
1.2
1.2
—
—
—
0
0
(4281824)
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
62
556
1.15
0.40
1.6
1.6
mmol/l
1.6
1.4
0.65
56
477
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
61
1.32
0.40
1.5
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
16
124
1.31
0.39
3.6
2.3
—
—
—
0
0
(4306422)
5
35
1.44
0.39
1.4
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.0
—
56.1
—
0
9
(3041096) Erythrocytes [Presence] in Urine by Automated
67
606
1.14
0.38
3.3
2.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
143
1.28
0.38
1.9
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
19
153
1.26
0.36
2.6
2.8
ml/min/173m2
79.2
70.2
—
10
67
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
253
0.82
0.35
1.7
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
188
0.79
0.34
1.4
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
74
1.37
0.33
1.5
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
32
365
0.86
0.30
3.2
2.6
ug/l
0.7
0.7
0.02
19
222
(21494755) Public health laboratory ask at order entry panel
26
301
0.85
0.29
1.3
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
39
347
1.15
0.29
1.6
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
129
0.77
0.29
2.1
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
13
103
1.28
0.28
1.8
2.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
64
1.26
0.27
1.1
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
8
65
1.24
0.27
7.0
5.7
%
1.0
0.9
—
8
59
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
207
2021
1.12
0.27
3.8
3.5
mmol/l
1.4
1.3
1.52
192
1881
(3028707) Methadone [Presence] in Urine by Screen method
8
66
1.22
0.27
1.6
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
8
66
1.22
0.27
2.9
1.9
pmol/l
160.6
226.9
—
8
61
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
8
66
1.22
0.27
7.0
5.7
%
1.8
1.5
—
8
59
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
67
1.20
0.26
1.0
1.8
—
—
—
0
0
(4034850)
5
73
0.68
0.26
6.0
9.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
170
0.81
0.26
1.4
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
2.2
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
97
1.25
0.23
2.3
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
45
490
0.90
0.22
3.8
4.0
%
19.8
20.7
0.11
17
219
(4035726)
19
163
1.18
0.22
1.2
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
217
2131
1.11
0.22
4.5
4.3
mmol/l
2.8
2.8
0.09
201
1995
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
103
0.77
0.21
1.8
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
5.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(4094501)
5
43
1.17
0.21
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
5
43
1.17
0.21
6.2
2.5
ug/min
254.0
75.8
—
5
29
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
13
0.00
0.21
0.0
1.6
—
1.5
—
0
8
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
48
1.26
0.20
1.3
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
25
222
1.14
0.20
2.2
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
109
1.20
0.19
14.2
4.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
58
1.21
0.18
1.6
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
205
2014
1.08
0.18
4.7
4.0
mmol/l
5.8
5.8
0.00
190
1865
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
66
625
1.07
0.17
4.9
4.4
ug/l
6.2
2.0
0.52
60
561
(3017446) Testosterone [Moles/volume] in Serum or Plasma
16
183
0.87
0.16
3.0
2.3
nmol/l
14.7
14.5
0.03
11
173
(3012516) Albumin [Mass/volume] in Urine
45
481
0.92
0.16
4.0
3.2
mg/l
30.1
205.2
0.65
32
310
(3002173) Hemoglobin [Mass/volume] in Arterial blood
18
159
1.14
0.15
12.1
8.4
g/l
126.7
122.7
0.28
18
151
(3020682) Albumin/Creatinine [Ratio] in Urine
48
511
0.93
0.15
5.2
3.8
mg/mmol
4.7
9.3
1.20
33
324
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
79
1.14
0.15
1.3
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
45
421
1.08
0.15
2.0
2.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
89
0.78
0.14
1.4
1.6
—
—
—
0
0
(3000492) Spirometry study
23
211
1.10
0.11
1.5
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
5
45
1.11
0.10
1.6
1.3
u/ml
194.3
232.6
—
5
29
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
6
54
1.11
0.09
1.5
1.8
—
4.8
—
0
18
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
134
0.89
0.09
1.1
1.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
57
1.05
0.08
1.7
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
6
58
1.04
0.08
9.3
6.1
mmol/l
1.1
1.2
—
6
50
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
5
60
0.83
0.08
4.4
2.5
mg/l
1.3
1.4
—
5
53
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
64
0.78
0.08
1.6
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
74
0.81
0.07
1.2
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
77
1.04
0.07
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
85
0.82
0.07
1.3
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
85
0.82
0.07
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
92
0.87
0.07
1.5
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
138
1.09
0.06
1.9
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
138
1.09
0.06
2.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
102
0.88
0.06
1.2
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
102
0.88
0.06
1.2
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
102
0.88
0.06
1.2
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
102
0.88
0.06
1.2
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
129
1.09
0.05
2.0
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
142
1402
1.03
0.05
3.9
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
83
813
1.03
0.05
3.7
3.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
139
1.08
0.05
1.9
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
110
1.10
0.05
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
111
1.08
0.04
2.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
45
462
0.97
0.04
3.8
3.4
kg/l
1.0
1.0
—
9
52
(36660697) Celiac disease serology panel - Serum
19
181
1.05
0.03
1.5
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
11
102
1.08
0.03
28.4
8.0
mmol/l
27.5
24.4
0.93
11
93
(3022145) Colonoscopy Study observation
24
232
1.04
0.02
1.1
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
57
561
1.02
0.02
3.6
2.9
mmol/l
8.0
8.1
0.06
47
469
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
117
0.94
0.02
1.4
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
183
1.04
0.01
1.8
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
227
0.97
0.01
10.2
6.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
383
1.02
0.01
1.8
2.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
104
1.06
0.01
4.6
5.2
mmol/l
24.1
24.6
0.15
11
104
(40761536) Microorganisms panel - Urine sediment
18
182
0.99
0.00
4.9
3.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
139
1.01
0.00
1.9
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
123
0.97
0.00
1.4
1.5
—
—
—
0
0
(4010399)
13
133
0.98
0.00
1.8
1.4
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
61
0.98
0.00
3.7
2.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
54
0.92
0.00
5.6
4.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
83
0.96
0.00
1.7
1.8
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
57
0.87
0.00
2.2
3.2
—
—
—
0
0
(3000012) Reticulocyte production index
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
53
0.94
0.00
1.0
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
60
1.00
0.00
1.7
1.3
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
29.2
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
31.1
—
0
8
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
61
0.98
0.00
1.2
2.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
6.5
—
0
9
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020891) Body temperature
6
69
0.87
0.00
27.0
4.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_INJURY_NERVES_ANKLE_FOOT_LEVEL – Injury of nerves at ankle and foot level

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).